Welcome to our dedicated page for cbdMD news (Ticker: YCBD), a resource for investors and traders seeking the latest updates and insights on cbdMD stock.
cbdMD, Inc. (NYSE American: YCBD) is a premier provider of high-quality, hemp-derived cannabidiol (CBD) products. Founded in 2015 and headquartered in Charlotte, North Carolina, cbdMD has quickly become one of the most highly trusted and recognized names in the CBD industry. The company offers a broad range of CBD products under its flagship brand cbdMD, as well as its pet-focused brand Paw CBD and its newly launched ATRx Labs line of functional mushroom supplements.
The company's product portfolio includes CBD tinctures, gummies, topicals, capsules, bath bombs, bath salts, sleep aids, and veterinarian-formulated pet CBD products like tinctures, chews, and topicals. It has built a robust distribution network, leveraging its own e-commerce platform, third-party online marketplaces, wholesalers, and a variety of brick-and-mortar retailers across the United States.
In recent developments, cbdMD has introduced innovative products such as the THCV+CBG Energy Softgels, which combine the potency of two dynamic cannabinoids with caffeine and B12 to enhance energy, focus, and clarity. The company's dedication to innovation is also evident in the launch of its CBD+CBG Oil Tincture and the introduction of a new Vice President of Wholesale Sales to expand its market reach.
Financially, cbdMD has been proactive in securing funding to support its growth. Recently, the company entered a securities purchase agreement, raising $1.25 million in gross proceeds to bolster working capital and support the national rollout of its ATRx Labs functional mushroom products. Despite reporting operational losses, cbdMD has implemented cost-cutting measures and strategic initiatives aimed at achieving profitability and enhancing shareholder value.
cbdMD's latest product,
cbdMD, Inc. (YCBD, YCBDPA) announced a multi-year exclusive agreement with Amify, an Amazon.com, Inc. (AMZN) partner, to launch CBD products on Amazon once the category is approved. This partnership includes cbdMD's leading products, such as gummies, tinctures, and skin care from cbdMD Botanicals. The agreement follows the growing interest in CBD since the Farm Bill's passage in 2018, positioning cbdMD to optimize its strategy for Amazon's platform. The company's Chairman emphasized readiness for market entry, enhancing cbdMD's distribution channels.
cbdMD, Inc. (NYSE: YCBD) has extended its advertising partnership with Spotify (NYSE: SPOT) and the Joe Rogan Experience (JRE) through 2022. The collaboration, which began in 2019, allows the company to tap into JRE's extensive audience, enhancing brand visibility in the CBD market. Co-CEO Martin Sumichrast emphasized the significance of this partnership, highlighting Rogan's credibility as a customer and advocate for the CBD community. cbdMD offers over 130 THC-free CBD products, contributing to its status as a leading brand in the industry.
cbdMD, Inc. (NYSE American: YCBD) will participate in the Jefferies Virtual West Coast Consumer Conference on November 16, 2021, with a fireside chat scheduled to begin at 9:50 AM ET. Investors can listen live via this link. cbdMD is a leading CBD brand, offering over 130 THC-free products including tinctures, gummies, and topicals, as well as a range of pet and beauty products. The company focuses on providing high-grade, U.S.-produced CBD solutions to consumers.
cbdMD, Inc. (NYSE American: YCBD) has appointed Matt Coapman as Chief Marketing Officer, bringing over 15 years of digital marketing and eCommerce experience. Previously, he was a Partner at Dingoz Consulting and the VP of Marketing for blu eCigs, where he significantly enhanced brand recognition. Coapman aims to drive sustainable growth, improve customer engagement, and enhance brand messaging within the CBD industry. cbdMD offers over 130 THC-free CBD products, including various SKUs for humans and pets, positioning itself as a leader in the market.
cbdMD, Inc. (NYSE American: YCBD) celebrated success at the Rogue Invitational, with athletes Justin Medeiros and Annie Thorisdottir winning gold and silver medals, respectively. The event took place in Austin, Texas, featuring top competitors in CrossFit. Medeiros praised his recovery routine post-CrossFit Games as key to his victory, while Thorisdottir expressed pride in her team's accomplishments. cbdMD's EVP of Sports Marketing, Hans Molenkamp, highlighted the athletes' achievements as inspiration, noting the brand's deep ties to the CrossFit community.
cbdMD has announced an exclusive partnership with Wodapalooza, the premier fitness festival happening from January 13-16, 2022, in Miami, Florida. As the Official CBD Partner, cbdMD will provide wellness solutions, product samples, and educational materials to athletes and gym owners. This partnership follows cbdMD's successful activation at the 2021 NOBULL CrossFit Games and aims to enhance its brand presence in the functional fitness community. The event will feature over $500k in prize money and aims to elevate the fitness community experience.
cbdMD, Inc. (NYSE American: YCBD) announced on October 7 the launch of cbdMD Therapeutics, a research division partnering with the University of Mississippi's National Center for Natural Products Research. The collaboration focuses on identifying and patenting novel cannabinoids for therapeutic use. Research will explore minor cannabinoids' chemistry, biology, and receptor activity, commencing in Fall 2021. Dr. Sibyl Swift emphasizes that this work sets a new standard in the cannabinoid industry, aiming for significant consumer benefits.
cbdMD, Inc. has entered a three-year exclusive partnership with Troon, the largest golf management company, to promote cbdMD products across over 600 affiliated facilities worldwide. This collaboration aims to enhance distribution opportunities for cbdMD's renowned CBD products, leveraging Troon's extensive network in the golf sector. The partnership features marketing initiatives including displays for retail locations, aiming to engage millions of golfing enthusiasts. This strategic move aligns with cbdMD's goal to expand its market reach, leveraging its brand ambassadors, including professional golfers.
cbdMD, Inc. (NYSE American: YCBD) has announced the launch of its new full spectrum product line, which includes tinctures and softgels with trace THC levels compliant with the 2018 Farm Bill. This expansion marks a significant milestone for the company, as full spectrum products account for over 50% of the total CBD market, according to the Brightfield Group. The introduction of these new offerings aims to broaden cbdMD's customer base while maintaining its commitment to THC-free options. Current available products can be found on cbdMD.com.
cbdMD, Inc. (NYSE American: YCBD) has partnered with four top CrossFit athletes, including 2021 champion Justin Medeiros and two-time champion Annie Thorisdottir, to enhance its presence in the fitness sector. This announcement follows their role as the Official CBD Partner of the 2021 NOBULL CrossFit Games. The partnerships aim to reach over three million Instagram followers and increase product awareness within the CrossFit community, which comprises around four million members globally.
FAQ
What is the current stock price of cbdMD (YCBD)?
What is the market cap of cbdMD (YCBD)?
What does cbdMD, Inc. specialize in?
What are cbdMD's latest product innovations?
How does cbdMD distribute its products?
What recent financial steps has cbdMD taken?
What is the significance of cbdMD's ATRx Labs line?
Is cbdMD financially stable?
What challenges is cbdMD currently facing?
Where is cbdMD headquartered?
Who recently joined the cbdMD team?
What are cbdMD's future plans?
